$4.96
0.122.48%
最終更新: Oct 12, 4:00 PM
Benzinga
Benzinga
Benzinga
月曜日, 10 12
Benzinga
© 2026 Benzinga | All Rights Reserved
Champions Oncology (CSBR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | $-0.05 | $0.09 | $0.01 |
| Actual | $0.05 | $0.01 | $0.04 | $0.06 |
| Surprise | — | +120.0% | -55.6% | +500.0% |
| Revenue | ||||
| Estimate | — | $12.9M | $16.6M | $14.0M |
| Actual | $15.2M | $13.8M | $16.6M | $15.0M |
| Surprise | — | +7.36% | -0.33% | +7.07% |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q4 | Jul 27, 2026 | $0.01 | $-0.05 | 120.0 % |
| Q3 | Mar 12, 2026 | $0.04 | $0.09 | -55.6 % |
| Q2 | Dec 15, 2025 | $0.06 | $0.01 | 500.0 % |
| Q1 | Sep 15, 2025 | $0.02 | $-0.01 | 300.0 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q4 | Jul 27, 2026 | $13.84M | $12.89M | 7.36 % |
| Q3 | Mar 12, 2026 | $16.56M | $16.61M | -0.33 % |
| Q2 | Dec 15, 2025 | $15.04M | $14.04M | 7.07 % |
| Q1 | Sep 15, 2025 | $14.00M | $13.51M | 3.57 % |